Objectif Plants can be considered as natural, solar energy powered, and environmentally friendly factories that can be improved for production of proteins with therapeutical value. However, current transgenic technologies are not accurate enough to secure reliable and precise protein production. Random chromosomal integration of transgenic inserts often causes misregulation of their transcription including complete gene silencing. Therefore the ability to modify plant genomes in a precise manner is arguably the most important missing technology in the toolkit of plant biologists. DNA integration, via homologous recombination (Gene targeting - GT) has proved a powerful technology in many species. It enables disruption, modification or replacement of an endogenous locu s by a new gene, in the native genomic context. Despite its success in other organisms, GT has not yet become a routine technique in plants. New findings, several of which from the TAGIP partners, suggest that GT became a realistic goal. To achieve this go al we propose to gain fundamental knowledge in the field of genome maintenance/modifications via DNA recombination and to apply this knowledge to develop new technologies for precise engineering of plant genomes. Finally, this knowledge will be harnessed f or the production of proteins of high value. Work will be carried in Arabidopsis and in model crop plants. The objectives of TAGIP are: -Development of new vectors and delivery methods for GT -Altering DNA recombination pathways to enhance GT -Application of GT for production of therapeutic proteins in plants The GT mechanism is a fundamental and open question. The tools and knowledge to be developed in TAGIP are relevant to agriculture (two small Agbiotech companies are active participants in the consortiu m) and medicine. The project is of particular importance for the EU states where public concern over the use of GMOs has generated a strong need for controlled integration of beneficial transgenic Champ scientifique sciences naturellessciences biologiquesgénétiqueADNsciences naturellessciences chimiqueschimie inorganiquemétal de transitionsciences naturellessciences biologiquesbiochimiebiomoléculeprotéinessciences agricolesagriculture, sylviculture et pêcheagriculturesciences naturellessciences biologiquesgénétiquegénome Programme(s) FP6-LIFESCIHEALTH - Life sciences, genomics and biotechnology for health: Thematic Priority 1 under the Focusing and Integrating Community Research programme 2002-2006. Thème(s) LSH-2004-1.1.0-1 - Topics for Specific Targeted Research Project in the area of Fundamental knowledge and basic tools for functional genomics in all organisms Appel à propositions FP6-2004-LIFESCIHEALTH-5 Voir d’autres projets de cet appel Régime de financement STREP - Specific Targeted Research Project Coordinateur WEIZMANN INSTITUTE OF SCIENCE Adresse Herzl st. 2 Rehovot Israël Voir sur la carte Liens Site web Opens in new window Contribution de l’UE Aucune donnée Participants (8) Trier par ordre alphabétique Trier par contribution de l’UE Tout développer Tout réduire CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE France Contribution de l’UE € 0,00 Adresse 2 avenue albert einstein Villeurbanne Voir sur la carte Liens Site web Opens in new window Autres sources de financement Aucune donnée UNIVERSITY OF KARLSRUHE (TH) Allemagne Contribution de l’UE € 0,00 Adresse Kaiserstr. 12 Karlsruhe Voir sur la carte Liens Site web Opens in new window Autres sources de financement Aucune donnée INSTITUTE OF EXPERIMENTAL BOTANY AS CR Tchéquie Contribution de l’UE € 0,00 Adresse Rozvojova 135 Praha 6 - lysolaje Voir sur la carte Liens Site web Opens in new window Autres sources de financement Aucune donnée UNIVERSITE DE GENEVE Suisse Contribution de l’UE € 0,00 Adresse 24,rue du general-dufour Geneva 4 Voir sur la carte Liens Site web Opens in new window Autres sources de financement Aucune donnée BIOGEMMA SAS France Contribution de l’UE € 0,00 Adresse 1 rue edouard colonne Paris Voir sur la carte Liens Site web Opens in new window Autres sources de financement Aucune donnée EVOGENE LTD Israël Contribution de l’UE € 0,00 Adresse 13 gad feinstein street Rehovot Voir sur la carte Liens Site web Opens in new window Autres sources de financement Aucune donnée NOVARTIS FORSCHUNGSSTIFTUNG, ZWEIGNIEDERLASSUNG FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH Suisse Contribution de l’UE € 0,00 Adresse Maulbeerstr. 66 ch-4058 Basel Voir sur la carte Liens Site web Opens in new window Autres sources de financement Aucune donnée O.S.M.-DAN LTD Israël Contribution de l’UE € 0,00 Adresse 38 hanassi harishon Rehovot Voir sur la carte Autres sources de financement Aucune donnée